Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases is described in US Provisional Patent Application No. 60 / 379,442 (filed May 10, 2002), US Provisional Patent Application No. 60 / 379,441 ( Filed May 10, 2002) and US Provisional Patent Application No. 60 / 379,474 (filed May 10, 2002), the contents of which are hereby incorporated by reference. It shall be described in the document.

摘要

The present invention relates to human lactoferrin for use in a method of reducing the growth of, or of shrinking, an established neoplasm by intratumoural administration of the human lactoferrin to a subject suffering from an established neoplasm in an amount sufficient to reduce the growth of, or shrink, the neoplasm in said subject.